Prostatic Neoplasm: Clinical Trials

13 trials for Prostatic Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Completed 13
Phase 12Completed 2
Phase 32Completed 2

Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).
I-131-1095, Enzalutamide - Metastatic Prostate Cancer, Castration-resistant Prostate Cancer
Phase 2CompletedProgenics Pharmaceuticals, Inc.1202019-05-302025-10-14
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
Estetrol, Placebo Oral Tablet - Prostatic Neoplasm
Phase 2CompletedPantarhei Oncology B.V.632018-04-162021-06-18
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm
Phase 2 / Phase 3CompletedMichael Graham PhD, MD302018-02-162024-07-12
68Ga PSMA in Preprostatectomy Patients
Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm
Phase 2 / Phase 3CompletedMichael Graham PhD, MD222018-02-162024-02-15
Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study
Perflutren Lipid Microsphere Intravenous Suspension - Prostatic Neoplasm
Phase 2CompletedThomas Jefferson University552017-02-012025-04-30
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
sipuleucel-T, leuprolide acetate - Prostatic Neoplasm, Prostate Cancer
Phase 2CompletedDendreon682011-09-012017-05-30
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
abiraterone acetate in combination with prednisone - Prostate Cancer, Prostatic Neoplasm
Phase 2CompletedJanssen Biotech, Inc.1312011-05-042026-02-24
Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer
radioimmuniguided intenstiy modulated radiotherapy - Prostatic Neoplasm
Phase 1 / Phase 2CompletedMayo Clinic722006-10-012011-02-25
Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer
SR31747A - Prostatic Neoplasm
Phase 2CompletedSanofi2322003-10-012008-12-23
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
STI571 (GlivecĀ®) - Prostatic Neoplasm, Genital Neoplasms, Male
Phase 2CompletedNovartis Pharmaceuticals512003-06-012017-06-01
Preop Conformal Radiotherapy - Prostate
Pre-Operative Conformal Radiotherapy - Prostatic Neoplasm
Phase 1 / Phase 2CompletedUniversity Health Network, Toronto152000-05-012010-08-11
A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer
thalidomide - Prostatic Neoplasm
Phase 2CompletedNational Cancer Institute (NCI)641995-09-012008-03-04
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma
Suramin - Prostatic Neoplasm
Phase 2CompletedNational Cancer Institute (NCI)701990-10-012008-03-04

Narrower conditions

Prostatic Neoplasms (13)  ·  Genital Neoplasms, Male (2)  ·  Neoplasms (2)  ·  Prostatic Diseases (2)  ·  Prostatic Neoplasms, Castration-Resistant (2)  ·  Urogenital Neoplasms (2)  ·  Abdominal Neoplasms (1)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Genital Diseases, Male (1)  ·  Hot Flashes (1)  ·  Neoplasms, Glandular and Epithelial (1)

Broader conditions

Genital Diseases (13)  ·  Male Urogenital Diseases (13)  ·  Neoplasms by Site (13)  ·  Urogenital Diseases (13)  ·  Genital Diseases, Male (12)  ·  Genital Neoplasms, Male (11)  ·  Neoplasms (11)  ·  Prostatic Diseases (11)  ·  Urogenital Neoplasms (11)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Neoplasms by Histologic Type (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Abiraterone Acetate (1)  ·  Estetrol (1)  ·  Imatinib Mesylate (1)  ·  Leuprolide (1)  ·  Prednisone (1)  ·  Suramin (1)  ·  Thalidomide (1)  ·  enzalutamide (1)  ·  luprolide acetate gel depot (1)  ·  perflutren (1)  ·  sipuleucel-T (1)

Sponsors

Michael Graham PhD, MD (2)  ·  National Cancer Institute (NCI) (2)  ·  Dendreon (1)  ·  Janssen Biotech, Inc. (1)  ·  Mayo Clinic (1)  ·  Novartis Pharmaceuticals (1)  ·  Pantarhei Oncology B.V. (1)  ·  Progenics Pharmaceuticals, Inc. (1)  ·  Sanofi (1)  ·  Thomas Jefferson University (1)  ·  University Health Network, Toronto (1)

Countries

United States (9)  ·  Canada (3)  ·  Netherlands (2)  ·  Australia (1)  ·  Belgium (1)  ·  Chile (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Poland (1)  ·  Portugal (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Ethan J Halpern, MD (1)  ·  Flemming Forsberg, PhD (1)  ·  Jean-Claude Provost, MD (1)  ·  Michael Graham, MD, PhD (1)  ·  Michael M. Graham, MD, PhD (1)  ·  Padraig Warde, MD (1)  ·  Robert Israel, MD (1)

Results publications

PMID 21106711

NIH funding

R21CA202214 (1)